Skip to main content

Find Clinical Trials

Home
Conditions
Thrombocytopenia

Clinical trial condition

Thrombocytopenia

Explore clinical trials studying Thrombocytopenia. Study availability and eligibility vary by location and protocol.

403 public trials 115 recruiting studies

Refine in advanced search Browse all conditions

Thrombocytopenia trial results

Not Yet Recruiting

The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

NCT07064889

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Peking University People's Hospital Beijing, China

View Trial Details

Not Yet Recruiting

Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP

NCT07057778

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Peking University Insititute of Hematology Beijing, China

View Trial Details

Not Yet Recruiting

Level of Serum Lactate Dehydrogenase in Immune Thrombocytopenia

NCT07046013

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"

NCT07014904

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY

NCT07019545

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: General Hospital of Athens "Alexandra", Athens, Attica Athens, Greece

View Trial Details

Not Yet Recruiting

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

NCT06873672

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +46 more
Locations: Guizhou Medical University Guiyang, Guizhou, China

View Trial Details

Not Yet Recruiting

Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure

NCT06790888

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus

NCT05504187

Conditions: Autoimmune Diseases, Blood Platelet Disorders, Connective Tissue Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura

NCT06137105

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Aspirin for Prophylaxis of TTP

NCT05568147

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations: Not specified

View Trial Details